论冠状动脉微血管疾病与肥胖之间的关系。 - Suppr

Suppr

超能文献

On the relationship between coronary microvascular disease and obesity.

作者信息

Pelletier-Galarneau Matthieu, Juneau Daniel

机构信息

Department of Medical Imaging, Institut de Cardiologie de Montréal, Montreal, QC, H1T 1C8, Canada.

Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

J Nucl Cardiol. 2022 Oct;29(5):2446-2447. doi: 10.1007/s12350-021-02835-z. Epub 2021 Oct 25.

DOI:10.1007/s12350-021-02835-z

PMID:34697786

Abstract

摘要

相似文献

On the relationship between coronary microvascular disease and obesity.

J Nucl Cardiol. 2022 Oct;29(5):2446-2447. doi: 10.1007/s12350-021-02835-z. Epub 2021 Oct 25.

Coronary Microvascular Dysfunction.

Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):1625-1637. doi: 10.1161/ATVBAHA.121.316025. Epub 2021 Mar 25.

Editorial commentary: Coronary microvascular dysfunction-Exploring the hidden part of the iceberg.

Trends Cardiovasc Med. 2022 Oct;32(7):454-455. doi: 10.1016/j.tcm.2021.08.013. Epub 2021 Aug 28.

Association Between Systemic Vasculitis and Coronary Microvascular Dysfunction in the Absence of Obstructive Coronary Artery Disease.

Circ Cardiovasc Imaging. 2023 Jan;16(1):e014940. doi: 10.1161/CIRCIMAGING.122.014940. Epub 2023 Jan 17.

Reply: Coronary Microvascular Dysfunction and HF: "There are None so Blind as Those Who Will Not See".

JACC Cardiovasc Interv. 2024 Jun 10;17(11):1407. doi: 10.1016/j.jcin.2024.04.041.

Coronary Microvascular Dysfunction and HF: "There Are None so Blind as Those Who Will Not See".

JACC Cardiovasc Interv. 2024 Jun 10;17(11):1406. doi: 10.1016/j.jcin.2024.04.032.

Angiography-based assessment of coronary microvascular function: First US report of IMRangio.

Cardiovasc Revasc Med. 2024 Mar;60:102-103. doi: 10.1016/j.carrev.2023.10.003. Epub 2023 Oct 5.

Coronary Microvascular Dysfunction Is Associated With Significant Plaque Burden and Diffuse Epicardial Atherosclerotic Disease.

JACC Cardiovasc Interv. 2019 Aug 12;12(15):1519-1520. doi: 10.1016/j.jcin.2019.05.003.

Letter by Vink et al Regarding Article, "Association of Hypertensive Disorders of Pregnancy With Coronary Microvascular Dysfunction 8 to 10 Years After Delivery".

Circ Cardiovasc Imaging. 2024 Aug;17(8):e017209. doi: 10.1161/CIRCIMAGING.124.017209. Epub 2024 Jul 30.

Sex differences in diagnostic modalities of coronary artery disease: Evidence from coronary microcirculation.

Atherosclerosis. 2023 Nov;384:117276. doi: 10.1016/j.atherosclerosis.2023.117276. Epub 2023 Sep 27.

引用本文的文献

Links Between Obstructive Sleep Apnea and Myocardial Blood Flow Changes Impacting Adverse Cardiovascular Disease-related Outcomes.

Curr Cardiol Rep. 2024 Jul;26(7):723-734. doi: 10.1007/s11886-024-02072-z. Epub 2024 May 28.

本文引用的文献

Microvascular Angina Diagnosed by Absolute PET Myocardial Blood Flow Quantification.

Curr Cardiol Rep. 2020 Jan 28;22(2):9. doi: 10.1007/s11886-020-1261-2.

Metabolically healthy obesity: what's in a name?

Am J Clin Nutr. 2019 Sep 1;110(3):533-539. doi: 10.1093/ajcn/nqz133.

Quantification of PET Myocardial Blood Flow.

Curr Cardiol Rep. 2019 Feb 28;21(3):11. doi: 10.1007/s11886-019-1096-x.

Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.

J Am Coll Cardiol. 2018 Aug 14;72(7):707-717. doi: 10.1016/j.jacc.2018.05.049.

Prevalence and characteristics of coronary microvascular dysfunction among chest pain patients in the emergency department.

Eur Heart J Acute Cardiovasc Care. 2020 Feb;9(1):5-13. doi: 10.1177/2048872618764418. Epub 2018 Mar 15.

International standardization of diagnostic criteria for microvascular angina.

Int J Cardiol. 2018 Jan 1;250:16-20. doi: 10.1016/j.ijcard.2017.08.068. Epub 2017 Sep 8.

Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis.

Eur J Prev Cardiol. 2016 Jun;23(9):956-66. doi: 10.1177/2047487315623884. Epub 2015 Dec 23.

Comparison of coronary vasodilation with intravenous dipyridamole and adenosine.

J Am Coll Cardiol. 1991 Aug;18(2):485-91. doi: 10.1016/0735-1097(91)90604-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

On the relationship between coronary microvascular disease and obesity.

J Nucl Cardiol. 2022 Oct;29(5):2446-2447. doi: 10.1007/s12350-021-02835-z. Epub 2021 Oct 25.

Coronary Microvascular Dysfunction.

Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):1625-1637. doi: 10.1161/ATVBAHA.121.316025. Epub 2021 Mar 25.

Editorial commentary: Coronary microvascular dysfunction-Exploring the hidden part of the iceberg.

Trends Cardiovasc Med. 2022 Oct;32(7):454-455. doi: 10.1016/j.tcm.2021.08.013. Epub 2021 Aug 28.

Association Between Systemic Vasculitis and Coronary Microvascular Dysfunction in the Absence of Obstructive Coronary Artery Disease.

Circ Cardiovasc Imaging. 2023 Jan;16(1):e014940. doi: 10.1161/CIRCIMAGING.122.014940. Epub 2023 Jan 17.

Reply: Coronary Microvascular Dysfunction and HF: "There are None so Blind as Those Who Will Not See".

JACC Cardiovasc Interv. 2024 Jun 10;17(11):1407. doi: 10.1016/j.jcin.2024.04.041.

Coronary Microvascular Dysfunction and HF: "There Are None so Blind as Those Who Will Not See".

JACC Cardiovasc Interv. 2024 Jun 10;17(11):1406. doi: 10.1016/j.jcin.2024.04.032.

Angiography-based assessment of coronary microvascular function: First US report of IMRangio.

Cardiovasc Revasc Med. 2024 Mar;60:102-103. doi: 10.1016/j.carrev.2023.10.003. Epub 2023 Oct 5.

Coronary Microvascular Dysfunction Is Associated With Significant Plaque Burden and Diffuse Epicardial Atherosclerotic Disease.

JACC Cardiovasc Interv. 2019 Aug 12;12(15):1519-1520. doi: 10.1016/j.jcin.2019.05.003.

Letter by Vink et al Regarding Article, "Association of Hypertensive Disorders of Pregnancy With Coronary Microvascular Dysfunction 8 to 10 Years After Delivery".

Circ Cardiovasc Imaging. 2024 Aug;17(8):e017209. doi: 10.1161/CIRCIMAGING.124.017209. Epub 2024 Jul 30.

Sex differences in diagnostic modalities of coronary artery disease: Evidence from coronary microcirculation.

Atherosclerosis. 2023 Nov;384:117276. doi: 10.1016/j.atherosclerosis.2023.117276. Epub 2023 Sep 27.

引用本文的文献

Links Between Obstructive Sleep Apnea and Myocardial Blood Flow Changes Impacting Adverse Cardiovascular Disease-related Outcomes.

Curr Cardiol Rep. 2024 Jul;26(7):723-734. doi: 10.1007/s11886-024-02072-z. Epub 2024 May 28.

本文引用的文献

Microvascular Angina Diagnosed by Absolute PET Myocardial Blood Flow Quantification.

Curr Cardiol Rep. 2020 Jan 28;22(2):9. doi: 10.1007/s11886-020-1261-2.

Metabolically healthy obesity: what's in a name?

Am J Clin Nutr. 2019 Sep 1;110(3):533-539. doi: 10.1093/ajcn/nqz133.

Quantification of PET Myocardial Blood Flow.

Curr Cardiol Rep. 2019 Feb 28;21(3):11. doi: 10.1007/s11886-019-1096-x.

Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.

J Am Coll Cardiol. 2018 Aug 14;72(7):707-717. doi: 10.1016/j.jacc.2018.05.049.

Prevalence and characteristics of coronary microvascular dysfunction among chest pain patients in the emergency department.

Eur Heart J Acute Cardiovasc Care. 2020 Feb;9(1):5-13. doi: 10.1177/2048872618764418. Epub 2018 Mar 15.

International standardization of diagnostic criteria for microvascular angina.

Int J Cardiol. 2018 Jan 1;250:16-20. doi: 10.1016/j.ijcard.2017.08.068. Epub 2017 Sep 8.

Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis.

Eur J Prev Cardiol. 2016 Jun;23(9):956-66. doi: 10.1177/2047487315623884. Epub 2015 Dec 23.

Comparison of coronary vasodilation with intravenous dipyridamole and adenosine.

J Am Coll Cardiol. 1991 Aug;18(2):485-91. doi: 10.1016/0735-1097(91)90604-8.